USFDA Audit Cleared - Bioanalytical Facility successfully closed an unannounced audit with zero observations | Global Recognition - CDMO Division participated as a Sponsor and Emerging Tech Partner at the European Pharma Outsourcing Summit (EPOS), Germany | Expanding Manufacturing Capabilities with enhanced capacity Dry Granulation (Roll Compactor), Low RH Manufacturing & High-Speed Capsule Filling

Clinical Studies (BA/BE/In-vitro)

Clinical Studies (BA/BE/In-vitro)

Nestled in the evolving state of Goa, VerGo Pharma (Clinicals Division) is a world-class Clinical Research Organization (CRO) built to meet global regulatory standards. With advanced infrastructure and scientific expertise, we deliver end-to-end solutions encompassing BA/BE studies, in-vitro research and diverse clinical services, supporting pharmaceutical and healthcare clients across highly regulated global markets.

 

Our Capabilities, Accreditations & Expertise in Clinical Studies:

  • Facility audited and approved by: CDSCO India, USFDA, UK MHRA, NPRA Malaysia, WHO-Geneva, CMPC Kazakhstan
  • 166-bed facility spread across 4 clinical units
  • Diversified database of 22,000+ volunteers
  • Conducted 850+ BA/BE Studies, across regulated markets
  • BA/BE studies on healthy volunteers & special populations – Solid Oral (Tablets/Capsules), Suspensions, Liquids, Suppositories, Oral Thin Films, Injectables
  • Comprehensive BA/BE solutions from protocol development to final eCTD dossier submission
  • Full-service Clinical Data Management and Regulatory Affairs support for bio-equivalence studies for global submissions
  • Robust Bio-analytical Capabilities: 260+ Validated Methods; 50+ Methods under development (including simultaneous estimations)
  • GLP-compliant Bio-analytical Lab equipped with 10 LCMS-MS
  • Pathology Lab: ISO 15189:2022 Certified; NABL Accredited
  • Independent in-vitro testing laboratory

 

Types of Studies

  • BA/BE
    • Fasting Studies
    • Fed Studies
    • Steady State (Multiple Dose Studies)
    • Pharmacokinetic Studies

 

  • In-Vitro Studies >> Click here to know more
    • IVRT Studies
    • IVPT Studies
    • In-vitro Enteral Feeding Tube Studies
    • BCS Studies
    • In-vitro Binding Studies

 

Dosage Forms Supported

  • Solid Oral (Tablets, Capsules)
  • Oral Suspensions & Liquids
  • Oral Thin Films
  • Suppositories
  • Injectables

 

Regulatory Track Record

VerGo Pharma has a proven history of successful inspections and approvals from leading global
authorities, including:

  • CDSCO (India)
  • USFDA
  • MHRA (UK)
  • NPRA (Malaysia)
  • WHO-Geneva
  • CMPC (Kazakhstan)

 

Strategic Advantage

VerGo Pharma delivers a unique edge by combining clinical expertise, quality compliance and global regulatory accreditation with the integrated strength of a CDMO + CRO model – all co-located in Goa.

  • Accelerated Development Timelines: Seamless transition from formulation and analytical development to clinical studies shortens pathways to approval.
  • Regulatory Confidence: Proven track record with global ensures smooth submissions and approvals.
    • Facility audited and approved by: CDSCO India, USFDA, UK MHRA, NPRA Malaysia, WHO-Geneva, CMPC Kazakhstan.
    • Our successful submissions to regulatory agencies includes EU, US, UK, Canada, ASEAN, LatAm, Australia & Emerging Markets.
  • Competitive Positioning: Quality-driven research and dossier readiness, enhance brand
    reputation and market success.
  • Integrated CDMO + CRO Advantage: One-partner solution for end-to-end drug development,
    from formulation scale-up to bioequivalence studies and dossier out-licensing or
    commercialisation.
  • Location Advantage: With both CDMO and CRO units being located in Goa, VerGo Pharma
    ensures operational efficiency, cost-effective scalability and seamless product development and
    commercialization.

Contact Us

Other Services